These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 29048428

  • 1. Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.
    Shlyakhtina Y, Pavet V, Gronemeyer H.
    Cell Death Dis; 2017 Aug 31; 8(8):e3025. PubMed ID: 29048428
    [Abstract] [Full Text] [Related]

  • 2. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J, Li G, Zhang K.
    Biomed Pharmacother; 2016 Dec 31; 84():1078-1087. PubMed ID: 27780136
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
    Shin D, Kwon HY, Sohn EJ, Nam MS, Kim JH, Lee JC, Ryu SY, Park B, Kim SH.
    Cell Physiol Biochem; 2015 Dec 31; 36(3):1151-62. PubMed ID: 26111475
    [Abstract] [Full Text] [Related]

  • 4. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.
    Nahacka Z, Svadlenka J, Peterka M, Ksandrova M, Benesova S, Neuzil J, Andera L.
    Biochim Biophys Acta Mol Cell Res; 2018 Mar 31; 1865(3):522-531. PubMed ID: 29278689
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAIL.
    Gómez-Benito M, Martinez-Lorenzo MJ, Anel A, Marzo I, Naval J.
    Exp Cell Res; 2007 Jul 01; 313(11):2378-88. PubMed ID: 17462628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.
    Song JH, Kandasamy K, Kraft AS.
    J Biol Chem; 2008 Sep 05; 283(36):25003-13. PubMed ID: 18599488
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
    Chen M, Wang X, Zha D, Cai F, Zhang W, He Y, Huang Q, Zhuang H, Hua ZC.
    Sci Rep; 2016 Oct 18; 6():35468. PubMed ID: 27752089
    [Abstract] [Full Text] [Related]

  • 13. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK.
    Prasad S, Yadav VR, Kannappan R, Aggarwal BB.
    J Biol Chem; 2011 Feb 18; 286(7):5546-57. PubMed ID: 21156789
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.
    Mazurek N, Byrd JC, Sun Y, Hafley M, Ramirez K, Burks J, Bresalier RS.
    Cell Death Differ; 2012 Mar 18; 19(3):523-33. PubMed ID: 21941373
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
    Hassanzadeh A, Farshdousti Hagh M, Alivand MR, Akbari AAM, Shams Asenjan K, Saraei R, Solali S.
    J Cell Physiol; 2018 Oct 18; 233(10):6470-6485. PubMed ID: 29741767
    [Abstract] [Full Text] [Related]

  • 17. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
    Azijli K, Yuvaraj S, van Roosmalen I, Flach K, Giovannetti E, Peters GJ, de Jong S, Kruyt FA.
    Apoptosis; 2013 Jul 18; 18(7):851-60. PubMed ID: 23456625
    [Abstract] [Full Text] [Related]

  • 18. Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
    Bui HTT, Le NH, Le QA, Kim SE, Lee S, Kang D.
    Int J Med Sci; 2019 Jul 18; 16(11):1412-1423. PubMed ID: 31673231
    [Abstract] [Full Text] [Related]

  • 19. High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde.
    Kim HB, Kim MJ, Kim DY, Lee JW, Bae JH, Kim DW, Kang CD, Kim SH.
    Mol Cancer; 2011 Apr 25; 10():46. PubMed ID: 21513580
    [Abstract] [Full Text] [Related]

  • 20. Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.
    Gasparian ME, Bychkov ML, Yagolovich AV, Dolgikh DA, Kirpichnikov MP.
    Biochemistry (Mosc); 2015 Aug 25; 80(8):1080-91. PubMed ID: 26547077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.